Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Carrier

Showing results (331-340 of 421) with videos related to

Pageof 43
Sort By:
TH Open : Companion Journal to Thrombosis and Haemostasis|July 12, 2023
Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of BleedingKimberly Snow Caroti, Cecilia Becattini, Marc Carrier, et al.
Thrombosis Research|October 6, 2023
Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort studyYan Xu, Faizan Khan, Michael J Kovacs, et al.
Thrombosis and Haemostasis|February 1, 2024
Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK StudyAlexander T Cohen, Christopher Wallenhorst, Marcella Rivera, et al.
Annals of Surgery|November 22, 2022
Efficacy and Safety of Anti-Xa-Guided Versus Fixed Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism in Trauma Patients: A Systematic Review and Meta-AnalysisAlexandre Tran, Shannon M Fernando, Rebecca S Gates, et al.
Gastroenterology|January 28, 2014
Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of GastroenterologyGeoffrey C Nguyen, Charles N Bernstein, Alain Bitton, et al.
Plos One|November 1, 2023
Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literatureJoseph R Shaw, Tyler James, Jonathan Douxfils, et al.
Thrombosis and Haemostasis|June 12, 2010
Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort studyGrégoire Le Gal, Michael J Kovacs, Marc Carrier, et al.
Journal of Thrombosis and Haemostasis : JTH|July 28, 2021
Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of AnticoagulationMatteo Candeloro, Nick van Es, Nathan Cantor, et al.
JACC. Cardiooncology|May 5, 2023
Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous ThromboembolismCraig I Coleman, Kimberly Snow Caroti, Khaled Abdelgawwad, et al.
The Journal of Surgical Research|August 26, 2025
Randomized Controlled Trials for the Prevention of Venous Thromboembolism in Trauma and Emergency General Surgery Patients: A Systematic Review of Sample Size MethodologiesKevin M Durr, Joseph Tropiano, Bram Rochwerg, et al.
Pageof 43

Showing results (331-340 of 421) with videos related to

Sort By:
Pageof 43
TH Open : Companion Journal to Thrombosis and Haemostasis|July 12, 2023
Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of BleedingKimberly Snow Caroti, Cecilia Becattini, Marc Carrier, et al.
Thrombosis Research|October 6, 2023
Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort studyYan Xu, Faizan Khan, Michael J Kovacs, et al.
Thrombosis and Haemostasis|February 1, 2024
Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK StudyAlexander T Cohen, Christopher Wallenhorst, Marcella Rivera, et al.
Annals of Surgery|November 22, 2022
Efficacy and Safety of Anti-Xa-Guided Versus Fixed Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism in Trauma Patients: A Systematic Review and Meta-AnalysisAlexandre Tran, Shannon M Fernando, Rebecca S Gates, et al.
Gastroenterology|January 28, 2014
Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of GastroenterologyGeoffrey C Nguyen, Charles N Bernstein, Alain Bitton, et al.
Plos One|November 1, 2023
Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literatureJoseph R Shaw, Tyler James, Jonathan Douxfils, et al.
Thrombosis and Haemostasis|June 12, 2010
Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort studyGrégoire Le Gal, Michael J Kovacs, Marc Carrier, et al.
Journal of Thrombosis and Haemostasis : JTH|July 28, 2021
Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of AnticoagulationMatteo Candeloro, Nick van Es, Nathan Cantor, et al.
JACC. Cardiooncology|May 5, 2023
Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous ThromboembolismCraig I Coleman, Kimberly Snow Caroti, Khaled Abdelgawwad, et al.
The Journal of Surgical Research|August 26, 2025
Randomized Controlled Trials for the Prevention of Venous Thromboembolism in Trauma and Emergency General Surgery Patients: A Systematic Review of Sample Size MethodologiesKevin M Durr, Joseph Tropiano, Bram Rochwerg, et al.
Pageof 43